Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Profit Margin (Quarterly): 7.95% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.95% |
| March 31, 2024 | -8.03% |
| December 31, 2023 | 3.44% |
| September 30, 2023 | -0.37% |
| June 30, 2023 | 8.83% |
| March 31, 2023 | -13.02% |
| December 31, 2022 | 12.04% |
| September 30, 2022 | 18.83% |
| June 30, 2022 | 6.50% |
| March 31, 2022 | -2.77% |
| December 31, 2021 | 17.87% |
| September 30, 2021 | 12.57% |
| June 30, 2021 | 9.41% |
| March 31, 2021 | -3.99% |
| December 31, 2020 | 18.46% |
| September 30, 2020 | 7.27% |
| June 30, 2020 | 16.42% |
| March 31, 2020 | 1.73% |
| December 31, 2019 | 18.19% |
| September 30, 2019 | 22.13% |
| June 30, 2019 | 17.51% |
| March 31, 2019 | 10.20% |
| December 31, 2018 | 24.49% |
| September 30, 2018 | 15.50% |
| June 30, 2018 | 16.58% |
| Date | Value |
|---|---|
| March 31, 2018 | 7.33% |
| December 31, 2017 | 16.82% |
| September 30, 2017 | 12.50% |
| June 30, 2017 | 13.17% |
| March 31, 2017 | 13.04% |
| December 31, 2016 | 18.01% |
| September 30, 2016 | 15.43% |
| June 30, 2016 | 19.72% |
| March 31, 2016 | 9.49% |
| December 31, 2015 | 16.29% |
| September 30, 2015 | 16.96% |
| June 30, 2015 | 12.98% |
| March 31, 2015 | 7.17% |
| December 31, 2014 | 12.49% |
| September 30, 2014 | 11.40% |
| June 30, 2014 | 12.15% |
| March 31, 2014 | 2.73% |
| December 31, 2013 | 11.69% |
| September 30, 2013 | 9.37% |
| June 30, 2013 | 7.36% |
| March 31, 2013 | 3.45% |
| December 31, 2012 | 9.78% |
| September 30, 2012 | 9.38% |
| June 30, 2012 | 14.59% |
| March 31, 2012 | -9.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.02%
Minimum
Mar 2023
18.83%
Maximum
Sep 2022
6.91%
Average
7.95%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Takeda Pharmaceutical Co Ltd | 7.83% |
| Nxera Pharma Co Ltd | 12.95% |
| PeptiDream Inc | 58.82% |
| Healios KK | -107.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 0.97% |
| Return on Assets | 0.46% |
| Return on Invested Capital | 0.66% |
| Gross Profit Margin (Quarterly) | 80.74% |
| Operating Margin (Quarterly) | 10.11% |
| Return on Net Operating Assets | 0.58% |